Drugs / Monovalent influenza A/H7N9 virus vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02586792 | Jan → Dec 2016 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent influenza A/H7N9 virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02586792 ↗ |
| Modality | Vaccine | “single dose of a monovalent inactivated influenza A/H7N9 virus vaccine” NCT02586792 ↗ |
| Route | Intramuscular | “All subjects will receive a single dose of the inactivated influenza A/H7N9 vaccine delivered intramuscularly.” NCT02586792 ↗ |